Recent research has identified the molecular processes of PARP14 as a new prospective therapeutic target for a variety of malignancies, such as prostate cancer, multiple myeloma, ovarian cancer, diffuse large B-cell lymphoma, and breast cancer. The gene discussed is PARP14; the disease is diffuse large B-cell lymphoma.